학술논문

A NOVEL CLASS OF T CELL-ACTIVATING ANTIBODY THAT SELECTIVELY TARGETS THE TCR B CHAIN TO PROMOTE ANTITUMOR ACTIVITY THROUGH ACTIVATION AND EXPANSION OF A NOVEL, POLYCLONAL EFFECTOR MEMORY T CELL SUBSET
Document Type
Journal
Source
JOURNAL FOR IMMUNOTHERAPY OF CANCER; NOV 2022, 10 pA1367-pA1367, 1p. Supplement: 2
Subject
Language
English
ISSN
20511426